-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse FrankfurtEURSymbol A28-
AffimedBörse Börse FrankfurtEURSymbol A28
-
AffimedBörse Börse BerlinEURSymbol A28
-
AffimedBörse Börse StuttgartEURSymbol A28
-
AFFIMED NVBörse Börse DüsseldorfEURSymbol A28
-
AFFIMED NVBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol A28
-
AFFIMED NVBörse Gettex System der Börse MünchenEURSymbol A28
-
AFFIMED NVBörse Quotrix System der Börse DüsseldorfEURSymbol A28
-
AffimedBörse NasdaqISIN NL0010872420 WKN: A12BHUUSDSymbol AFMD
-
ISIN NL0010872420 WKN: A12BHUUSDSymbol AFMD
-
EURSymbol A28
-
Affimed N.V.Börse London Stock Exchange
-
Symbol A28
Währung
EUR
Börse
Börse Frankfurt Zeitzone: Europe/Berlin
Firmenname
Affimed N.V
Marktkapitalisierung
703.653.728 (+- 1%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
693.307.456 oder 714.000.000
Mitarbeiter
178 (+- 23%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
137 oder 219 Mitarbeiter
EBITDA 0
Buchwert 0.669
Affimed underperformed den DAX um -53 % vom 06.10.2014 bis 23.07.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 4,8 USD +7,62%
Portrait der Affimed Aktie
Das Unternehmen Affimed N.V aus Niederlande beschäftigt 178 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Die Affimed Aktie konnte seit dem 06.10.2014 eine Rendite von 14% erwirtschaften.
Das Unternehmen Affimed N.V ist nur in einem ETFs enthalten und somit ein unbekanntes oder von Investoren gemiedenes Unternehmen. Der ETF iShares Nasdaq US Biotechnology UCITS ETF gewichtet Affimed mit 0,06%.
Ein ETF investiert in Affimed N.V
Dir gefallen die Informationen zu Affimed?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Affimed?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Affimed?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Affimed?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
27 News & Informationen zur Affimed Aktie
XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events
Added six assets to its portfolio of potential milestone and royalty assets in 2021 Company earned $0.5 million milestone as Janssen asset entered Phase 3…
Affimed Announces Publication Of Comprehensive Preclinical Data Demonstrating The Therapeutic Potential Of AFM24 In EGFR-expressing Tumors
AFM24 is an innate cell engager with a novel and distinctive mechanism of action, designed to address the need of broader patient populations than current
15 Stocks that Will Double In 2021
In this article, we discuss the 15 stocks that will double in 2021. If you want to skip our detailed analysis of these stocks, go directly to the 5 Stocks…
Were Hedge Funds Right About Gogo Inc (GOGO)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Were Hedge Funds Right About The Lovesac Company (LOVE)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
3 Biotech Stocks That Could Rocket Higher
Over the past year, these small-cap drugmakers have done well by their shareholders, and more big catalysts could be coming.
3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120%
Hedge Funds Are Crazy About Affimed NV (AFMD)
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors…
Affimed: Remaining Bullish Despite Study Discontinuation (NASDAQ:AFMD)
Affimed recently reported their Q1 earnings that revealed a solid beat on EPS and revenue. However, the company also announced that Genentech has stopped one of their partnered programs.
Affimed: Current Fall And Future Prospects (NASDAQ:AFMD)
Affimed did well in the last 12 months, but has been seeing a correction lately. Given a data rich 2021, the correction is not correct. The current stock price looks attractive.
Affimed N.V.'s (AFMD) CEO Adi Hoess on Q1 2021 Results – Earnings Call Transcript
Affimed N.V. (NASDAQ:AFMD) Q1 2021 Earnings Conference Call July 1, 2021 08:30 AM ET Company Participants Alexander Fudukidis – Head of Investor Relations Adi Hoess – Chief Executive…
Affimed N.V. (AFMD) CEO Adi Hoess on Q1 2021 Results – Earnings Call Transcript
Affimed N.V. (NASDAQ:AFMD) Q1 2021 Earnings Conference Call July 1, 2021 08:30 AM ET Company Participants Alexander Fudukidis – Head of Investor Relations Adi Hoess – Chief Executive…
(NASDAQ:AFMD)Affimed posts Q1 topline beat, provides cash runway update
Affimed (AFMD) posted first-quarter revenue that beat Wall Street estimates, and said that itexpects the company's cash and cash equivalents to support operations into the second half…
Affimed N : Unaudited consolidated statements of comprehensive income / (loss) (in ? thousand) (Form 6-K)
net
4
5,499
… | July 1, 2021
Affimed N : Reports First Quarter 2021 Financial Results and Highlights Operational Progress
AFM13 monotherapy: Reported positive outcome from the preplanned interim analysis for the registration-directed trial in PTCL; enrollment expected to be completed in the… | July 1, 2021
Earnings Scheduled For July 1, 2021
Companies Reporting Before The Bell
• Simply Good Foods (NASDAQ:SMPL) is projected to report quarterly earnings at $0.29 per share on revenue of …
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (…
Affimed to Report First Quarter 2021 Financial Results & Corporate Update July 1, 2021
HEIDELBERG, Germany, June 22, 2021 — Affimed N.V. , a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it… | June 22, 2021
Why Affimed N.V. Stock Dropped Today
The company's latest quarterly update was less than impressive.
Affimed NV Shares Rise 20% on Initial Data from Phase 1 R/R CD30-Positive Lymphoma Trial
Affimed NV Stock Appears To Be Significantly Overvalued
Affimed NV Stock Appears To Be Significantly Overvalued, Stocks: AFMD, release date:Apr 11, 2021
Affimed (AFMD) Catches Eye: Stock Jumps 8.8%
Affimed (AFMD) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
80 Biggest Movers From Yesterday
Gainers Live Ventures Incorporated (NASDAQ:LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a profit in the …
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 12) …
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Biolase (NASDAQ:BIOL) stock rose 22.11% to $1.27 during Tuesday's after-market session. At the close, Biolase's trading volume reached 14.5 …
Affimed Announces Proposed Public Offering of Common Shares
Heidelberg, Germany, January 12, 2021 – Affimed N.V. (“Affimed” or the “Company”) (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Aileron Therapeutics (NASDAQ:ALRN) stock moved upwards by 33.25% to $1.8 during Friday’s after-market session. This security traded at a volume …